Spyre Therapeutics files 8-K/A to correct date on cover page of prior filing

Spyre Therapeutics, Inc.

Amendment corrects clerical error on cover page date of Original 8-K filed August 7, 2024.
No changes to financial results, disclosures, or exhibits from the original report.
Original 8-K reported Q2 2024 financials; this filing only revises the report date.
No new material information for investors; purely administrative correction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.